Lynparza 150 mg olaparib film‑coated Tablets × 112

Lynparza contains the active substance olaparib.

• • Olaparib is a cancer medicine called a PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor).

• • PARP inhibitors can destroy cancer cells that are poor at repairing DNA damage.

These specific cancer cells can be identified by:

• • Response to chemotherapy (cytotoxin) containing platinum, or

• To look for faulty dna repair genes, such as brca (a breast cancer gene)

Ingredints:

The active substance is olaparib.

• • Each Lynparza 150 mg film-coated tablet contains 150 mg olaparib.

What Lynparza looks like and contents of the pack:

• Lynparza 150 mg tablets are green to grey-green, oval, biconvex tablets, debossed with “OP150” on one side and plain on the other.